Magnesium carbonate: Difference between revisions

Magnesium carbonate
	Adult Indications & Dosage
	Pediatric Indications & Dosage
	Contraindications
	Warnings & Precautions
	Adverse Reactions
	Drug Interactions
	Use in Specific Populations
	Administration & Monitoring
	Overdosage
	Pharmacology
	Clinical Studies
	How Supplied
	Images
	Patient Counseling Information
	Precautions with Alcohol
	Brand Names
	Look-Alike Names

VisualWikitext

Latest revision as of 16:38, 20 August 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Magnesium carbonate is a {{{drugClass}}} that is FDA approved for the treatment of indigestion. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indigestion

For the temporary relief of upset stomach or sour stomach, and acid indigestion.

Dosing Information

The dose of magnesium hydroxide liquid as an antacid is 400 to 1200 milligrams orally up to 4 times daily.
For the treatment of indigestion, the dose of magnesium oxide tablets is 800 milligrams (482.6 mg elemental magnesium) orally daily with food.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Magnesium carbonate in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Magnesium carbonate in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding FDA-Labeled Use of Magnesium carbonate in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Magnesium carbonate in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Magnesium carbonate in pediatric patients.

Contraindications

Warnings

Do not use if you have kidney desease.
Do not take more than the maximum recommended daily dose (Adults 8 tsps. - children 4 tsps.), or use the maximum dosage of this product for more than 2 weeks, except under the advice and supervision of a doctor.
May have laxative effect.
If you are taking prescription drugs. Antacids may interact with certain prescription drugs.
In the case of accidental overdose, seek professional assistance or contact a Poison Control center immediately.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Magnesium carbonate in the drug label.

Postmarketing Experience

There is limited information regarding Postmarketing Experience of Magnesium carbonate in the drug label.

Drug Interactions

There is limited information regarding Magnesium carbonate Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

Pregnancy Category

Pregnancy Category (AUS):

Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Magnesium carbonate in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Magnesium carbonate during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Magnesium carbonate with respect to nursing mothers.

Pediatric Use

There is no FDA guidance on the use of Magnesium carbonate with respect to pediatric patients.

Geriatic Use

There is no FDA guidance on the use of Magnesium carbonate with respect to geriatric patients.

Gender

There is no FDA guidance on the use of Magnesium carbonate with respect to specific gender populations.

Race

There is no FDA guidance on the use of Magnesium carbonate with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Magnesium carbonate in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Magnesium carbonate in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Magnesium carbonate in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Magnesium carbonate in patients who are immunocompromised.

Administration and Monitoring

Administration

Intravenous

Monitoring

There is limited information regarding Monitoring of Magnesium carbonate in the drug label.

Description

IV Compatibility

There is limited information regarding IV Compatibility of Magnesium carbonate in the drug label.

Overdosage

There is limited information regarding Chronic Overdose of Magnesium carbonate in the drug label.

Pharmacology

Mechanism of Action

Structure

There is limited information regarding Magnesium carbonate Structure in the drug label.

Pharmacodynamics

There is limited information regarding Pharmacodynamics of Magnesium carbonate in the drug label.

Pharmacokinetics

There is limited information regarding Pharmacokinetics of Magnesium carbonate in the drug label.

Nonclinical Toxicology

There is limited information regarding Nonclinical Toxicology of Magnesium carbonate in the drug label.

Clinical Studies

There is limited information regarding Clinical Studies of Magnesium carbonate in the drug label.

How Supplied

There is limited information regarding Magnesium carbonate How Supplied in the drug label.

Storage

There is limited information regarding Magnesium carbonate Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Magnesium carbonate |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Magnesium carbonate |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

(Shake well before using)

Follow dosage below or as directed by a doctor.

Adults and children 12 yrs. and older: 2 tsps. every 3 to 4 hrs.

Children 6 to 12 yrs. of age: 1 tsp. every 3 to 4 hrs.

Children under 2 yrs. of age: consult a doctor before use.

Precautions with Alcohol

Alcohol-Magnesium carbonate interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

®^[1]

Look-Alike Drug Names

A® — B®^[2]

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

↑ Empty citation (help)
↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject:

 |Page Name=Magnesium carbonate
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject:

 |Label Page=Magnesium carbonate
 |Label Name=Magnesium carbonate11.png

}}

{{#subobject:

 |Label Page=Magnesium carbonate
 |Label Name=Magnesium carbonate11.png

}}

[1] Empty citation (help)

[www.ismp.org-2] "http://www.ismp.org". External link in |title= (help)

[1]

[2]

@@ Line 1: / Line 1: @@
 {{DrugProjectFormSinglePage
 |authorTag={{DB}}
+|genericName=Magnesium carbonate
 |aOrAn=a
-|hasBlackBoxWarning=Yes
+|indicationType=treatment
-|adverseReactions=<!--Black Box Warning-->
+|indication=[[indigestion]]
 |blackBoxWarningTitle=<span style="color:#FF0000;">ConditionName: </span>
 |blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
@@ Line 14: / Line 15: @@
 |fdaLIADAdult======Indigestion=====
-* For the temporary relief of upset stomach or sour stomach, and acid indigestion.
+* For the temporary relief of upset stomach or sour stomach, and acid [[indigestion]].
 * Dosing Information
@@ Line 24: / Line 25: @@
 <!--Guideline-Supported Use (Adult)-->
-|offLabelAdultGuideSupport======Condition1=====
+|offLabelAdultGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Non–Guideline-Supported Use (Adult)-->
-|offLabelAdultNoGuideSupport======Condition1=====
+|offLabelAdultNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in adult patients.
 <!--Pediatric Indications and Dosage-->
 <!--FDA-Labeled Indications and Dosage (Pediatric)-->
-|fdaLIADPed======Condition1=====
+|fdaLIADPed=* There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>FDA-Labeled Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Off-Label Use and Dosage (Pediatric)-->
 <!--Guideline-Supported Use (Pediatric)-->
-|offLabelPedGuideSupport======Condition1=====
+|offLabelPedGuideSupport=* There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-* Developed by:
-* Class of Recommendation:
-* Strength of Evidence:
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Non–Guideline-Supported Use (Pediatric)-->
-|offLabelPedNoGuideSupport======Condition1=====
+|offLabelPedNoGuideSupport=* There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
-* Dosing Information
-:* Dosage
-=====Condition2=====
-There is limited information regarding <i>Off-Label Non–Guideline-Supported Use</i> of {{PAGENAME}} in pediatric patients.
 <!--Contraindications-->
-|contraindications=* Condition1
+|contraindications=*
 <!--Warnings-->
@@ Line 103: / Line 52: @@
 * If you are taking prescription drugs. Antacids may interact with certain prescription drugs.
 * In the case of accidental overdose, seek professional assistance or contact a Poison Control center immediately.
-|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
+|clinicalTrials=* There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
-=====Body as a Whole=====
-=====Cardiovascular=====
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
 <!--Postmarketing Experience-->
-|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
+|postmarketing=* There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
-=====Body as a Whole=====
-=====Cardiovascular=====
-=====Digestive=====
-=====Endocrine=====
-=====Hematologic and Lymphatic=====
-=====Metabolic and Nutritional=====
-=====Musculoskeletal=====
-=====Neurologic=====
-=====Respiratory=====
-=====Skin and Hypersensitivy Reactions=====
-=====Special Senses=====
-=====Urogenital=====
-=====Miscellaneous=====
 <!--Drug Interactions-->
-|drugInteractions=* Drug
+|drugInteractions=<!--Use in Specific Populations-->
-:* Description
-<!--Use in Specific Populations-->
 |useInPregnancyFDA=* '''Pregnancy Category'''
 |useInPregnancyAUS=* '''Australian Drug Evaluation Committee (ADEC) Pregnancy Category'''
-There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
+*There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
-|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
+|useInLaborDelivery=* There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
-|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
+|useInNursing=* There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
-|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
+|useInPed=* There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
-|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
+|useInGeri=* There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
-|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
+|useInGender=* There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
-|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
+|useInRace=* There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
-|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
+|useInRenalImpair=* There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
-|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
+|useInHepaticImpair=* There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
-|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
+|useInReproPotential=* There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
-|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
+|useInImmunocomp=* There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
 <!--Administration and Monitoring-->
-|administration=* Oral
+|administration=*
 * Intravenous
-|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
+|monitoring=* There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
 * Description
 <!--IV Compatibility-->
-|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
+|IVCompat=* There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
 <!--Overdosage-->
-|overdose====Acute Overdose===
+|overdose=* There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
-====Signs and Symptoms====
-* Description
-====Management====
-* Description
-===Chronic Overdose===
-There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
 <!--Pharmacology-->
 <!--Drug box 2-->
-|drugBox=<!--Mechanism of Action-->
+|drugBox=[[File:Magnesium carbonate wiki.png|600px|thumbnail|left]]
+{{clear}}
 |mechAction=*
 <!--Structure-->
-|structure=*
+|structure=<!--Pharmacodynamics-->
+|PD=* There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
-: [[File:{{PAGENAME}}01.png|thumb|none|600px|This image is provided by the National Library of Medicine.]]
-<!--Pharmacodynamics-->
-|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
 <!--Pharmacokinetics-->
-|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
+|PK=* There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
 <!--Nonclinical Toxicology-->
-|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
+|nonClinToxic=* There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
 <!--Clinical Studies-->
-|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
+|clinicalStudies=* There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
 <!--How Supplied-->
-|howSupplied=*
 |packLabel=[[File:Magnesium carbonate pdp.jpg|600px|thumbnail|left]]
 {{clear}}
+[[File:Magnesium carbonate label.png|600px|thumbnail|left]]
+{{clear}}
 |fdaPatientInfo=*(Shake well before using)

Magnesium carbonate: Difference between revisions

Latest revision as of 16:38, 20 August 2015

Disclaimer

Overview

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Indigestion

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Non–Guideline-Supported Use

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Non–Guideline-Supported Use

Contraindications

Warnings

Adverse Reactions

Clinical Trials Experience

Postmarketing Experience

Drug Interactions

Use in Specific Populations

Pregnancy

Labor and Delivery

Nursing Mothers

Pediatric Use

Geriatic Use

Gender

Race

Renal Impairment

Hepatic Impairment

Females of Reproductive Potential and Males

Immunocompromised Patients

Administration and Monitoring

Administration

Monitoring

IV Compatibility

Overdosage

Pharmacology

Mechanism of Action

Structure

Pharmacodynamics

Pharmacokinetics

Nonclinical Toxicology

Clinical Studies

How Supplied

Storage

Images

Drug Images

Package and Label Display Panel

Patient Counseling Information

Precautions with Alcohol

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

Navigation menu